EC approves venetoclax in combo with rituximabNovember 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Weighing the costs of CAR T-cell therapyOctober 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLAggressive Lymphomas
Blinatumomab approved to treat ALL in JapanSeptember 26, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
FDA approves duvelisib for CLL/SLL and FLSeptember 25, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
FLT3 inhibitor approved for rel/ref AML in JapanSeptember 25, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Drug approved as part of frontline therapy for HLSeptember 25, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Product approved to treat hemophilia A in JapanSeptember 25, 2018ThrombosisPharmacyBleeding Disorders
CHMP reconsiders new indication for blinatumomabSeptember 24, 2018Leukemia, Myelodysplasia, TransplantationPharmacyALL
CHMP backs proposed biosimilars of pegfilgrastimSeptember 24, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
CHMP recommends factor VIII therapy for hemophilia ASeptember 24, 2018ThrombosisPharmacyBleeding Disorders
CHMP supports new indication for venetoclaxSeptember 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends mogamulizumab for MF, SSSeptember 22, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA approves drug for hairy cell leukemiaSeptember 14, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma